Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0284-2024Class II

Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210

Philips North America LLC / initiated 2023-10-09 / Completed / root cause: software

Philips Ultrasound, Inc. began a recall of Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210 on . FDA classified it as Class II and gives the reason as "Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image". As of , the recall status on record is Completed, and MDM tags the root cause as software.

Recall record

Recall number
Z-0284-2024
Classification
Class II
Status
Completed
Initiated
Posted
Recalling firm
Philips North America LLC
Product
Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210
Product code
IYN System, Imaging, Pulsed Doppler, Ultrasonic
Reason for recall
Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image.
Root cause tag
software
FDA root cause
Software design
Action
On October 9, 2023, Philips issued a Urgent Medical Device Correction notification to affected consignees. Philips asked consignees to take the following actions: 1. Identify if your firm has an affected product. 2. In the 2D tab in the system touchscreen, disable the AutoSCAN feature every time a transducer or a Transducer preset is selected to prevent the system from potentially experiencing image lag issue. The AutoSCAN feature is disabled when the button is not highlighted in amber. 3. Please complete and return the attached response form to Philips promptly and no later than 15 days from receipt. Completing this form confirms receipt of the Urgent Medical Device Correction Letter, understanding of the issue, and required actions to be taken. 4. Circulate this Urgent Medical Device Correction Letter to all users of this device so that they are aware of the issue. Please retain this letter with your system(s) and ensure the letter is in a place likely to be seen/viewed. 5. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, or by regular mail, or by fax.
Quantity in commerce
7 systems
Distribution
US: AZ, CA, CT, FL, GA, ID, IL, KY, MD, MT, NE, NV, OH, TN, TX, UT, VA OUS: Canada
Product codes and lots
Following serial numbers operating with software version 10.0. Model 795210/UDI: (01)00884838106611/Serial Numbers: US523F1930 US918F1158 US918F1159 US723F1377 US523F1496 US523F1497 US217F0292

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0284-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0283-2024Class IICompletedVoluntary: Firm initiated
Z-0284-2024Class IICompletedVoluntary: Firm initiated